Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus - PubMed (original) (raw)

Comparative Study

Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus

T Zürcher et al. J Virol. 1992 Aug.

Abstract

The interferon-induced Mx1 protein of mice confers selective resistance to influenza virus. It inhibits viral mRNA synthesis in the nucleus of influenza virus-infected cells. The related human MxA protein is localized in the cytoplasm and can inhibit influenza virus and vesicular stomatitis virus but not other viruses. MxA blocks a poorly defined cytoplasmic multiplication step of influenza virus that follows primary transcription of the viral genome. We previously showed that nuclear variants of MxA that carry an artificial nuclear translocation signal were also active against influenza virus. However, these variants blocked primary transcription of influenza virus. In the present study, we addressed the question of whether cytoplasmic forms of Mx1 were capable of mimicking the antiviral action of MxA by determining the antiviral activities of mutant mouse Mx1 protein. Cytoplasmic Mx1(E614), which differs from wild-type Mx1 by a single amino acid substitution in its nuclear transport signal, failed to inhibit the multiplication of influenza virus and vesicular stomatitis virus. Relocation of Mx1(E614) to the nucleus with the help of the simian virus 40 large T nuclear translocation signal attached to its amino terminus restored the influenza virus-inhibiting activity. Other changes in the carboxy-terminal region of Mx1 also abolished transport to the nucleus and simultaneously abolished antiviral activity. One of these variants, Mx1/A, gained activity against influenza virus upon relocation to the nucleus. These results demonstrate that unlike human MxA, the mouse Mx1 protein can function only in the nucleus. This finding has important implications regarding the mechanistic details of Mx protein action.

PubMed Disclaimer

Similar articles

• Mechanism of human MxA protein action: variants with changed antiviral properties.
  Zürcher T, Pavlovic J, Staeheli P. Zürcher T, et al. EMBO J. 1992 Apr;11(4):1657-61. doi: 10.1002/j.1460-2075.1992.tb05212.x. EMBO J. 1992. PMID: 1314172 Free PMC article.
• Mx proteins: GTPases involved in the interferon-induced antiviral state.
  Pavlovic J, Schröder A, Blank A, Pitossi F, Staeheli P. Pavlovic J, et al. Ciba Found Symp. 1993;176:233-43; discussion 243-7. doi: 10.1002/9780470514450.ch15. Ciba Found Symp. 1993. PMID: 7507812 Review.
• Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle.
  Pavlovic J, Haller O, Staeheli P. Pavlovic J, et al. J Virol. 1992 Apr;66(4):2564-9. doi: 10.1128/JVI.66.4.2564-2569.1992. J Virol. 1992. PMID: 1548781 Free PMC article.
• Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity.
  Ponten A, Sick C, Weeber M, Haller O, Kochs G. Ponten A, et al. J Virol. 1997 Apr;71(4):2591-9. doi: 10.1128/JVI.71.4.2591-2599.1997. J Virol. 1997. PMID: 9060610 Free PMC article.
• [The Mx protein that confers the resistance to influenza virus].
  Nagata K, Mibayashi M. Nagata K, et al. Nihon Rinsho. 1997 Oct;55(10):2654-9. Nihon Rinsho. 1997. PMID: 9360386 Review. Japanese.

Cited by

• Murine GFP-Mx1 forms nuclear condensates and associates with cytoplasmic intermediate filaments: Novel antiviral activity against VSV.
  Sehgal PB, Yuan H, Scott MF, Deng Y, Liang FX, Mackiewicz A. Sehgal PB, et al. J Biol Chem. 2020 Dec 25;295(52):18023-18035. doi: 10.1074/jbc.RA120.015661. Epub 2020 Oct 19. J Biol Chem. 2020. PMID: 33077519 Free PMC article.
• Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells.
  Matzinger SR, Carroll TD, Dutra JC, Ma ZM, Miller CJ. Matzinger SR, et al. J Virol. 2013 Jan;87(2):1150-8. doi: 10.1128/JVI.02271-12. Epub 2012 Nov 14. J Virol. 2013. PMID: 23152507 Free PMC article.
• Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
  Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de Thé H. Chelbi-Alix MK, et al. J Virol. 1998 Feb;72(2):1043-51. doi: 10.1128/JVI.72.2.1043-1051.1998. J Virol. 1998. PMID: 9444998 Free PMC article.
• Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.
  Singh DK, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger LS, Artyomov MN, Khader SA, Kaushal D. Singh DK, et al. Nat Commun. 2022 Feb 3;13(1):679. doi: 10.1038/s41467-022-28315-7. Nat Commun. 2022. PMID: 35115549 Free PMC article.
• Identification of the murine Mx2 gene: interferon-induced expression of the Mx2 protein from the feral mouse gene confers resistance to vesicular stomatitis virus.
  Jin HK, Takada A, Kon Y, Haller O, Watanabe T. Jin HK, et al. J Virol. 1999 Jun;73(6):4925-30. doi: 10.1128/JVI.73.6.4925-4930.1999. J Virol. 1999. PMID: 10233954 Free PMC article.

References

1. 1. J Virol. 1990 Jul;64(7):3370-5 - PubMed
2. 1. J Virol. 1991 Jan;65(1):245-53 - PubMed
3. 1. J Interferon Res. 1987 Oct;7(5):657-69 - PubMed
4. 1. Mol Cell Biol. 1989 Nov;9(11):5062-72 - PubMed
5. 1. J Interferon Res. 1987 Aug;7(4):331-43 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)